F
$ Value
$30K
Shares
901
Price
$33
Filed
Apr 13
Insider
Name
Lurker Nancy
Title
—
CIK
0001450485
Roles
Director
Transaction Details
Transaction Date
2026-04-11
Code
F
Table
Non-Derivative
Ownership
Direct
Equity Swap
No
Shares After
13,555
Footnotes
Each restricted stock unit represents a contingent right to receive one ordinary share. | Shares subject to the restricted stock unit award vest in three equal annual installments commencing on 4/11/2025.
Filing Info
Lurker Nancy's History
| Date | Ticker | Type | Value |
|---|---|---|---|
| 2026-04-11 | ALKS | M | — |
| 2026-04-11 | ALKS | F | $30K |
| 2026-04-11 | ALKS | M | — |
| 2025-07-10 | EYPT | M | $0 |
| 2025-07-10 | EYPT | M | $0 |
| 2025-07-02 | EYPT | G | $0 |
| 2025-07-02 | EYPT | G | $0 |
| 2025-07-02 | EYPT | G | $0 |
| 2025-07-02 | EYPT | G | $0 |
| 2025-07-02 | EYPT | G | $0 |
Other Insiders at ALKS (90d)
| Insider | Bought | Sold | Last |
|---|---|---|---|
| Lurker Nancy | — | — | 2026-04-11 |
|
Gaffin David Joseph
EVP, CLO, Alkermes, Inc.
|
— | $70K | 2026-04-06 |
|
Hopkinson Craig C.
EVP R&D, Chief Medical Officer
|
— | $320K | 2026-04-01 |